40th Annual J.P. Morgan HealthCare Conference

Keynotes

Jamie Dimon

Chairman and Chief Executive Officer,

JPMorgan Chase & Co.

Full Bio

Jessica Fye

Managing Director, Equity Research - Biotech,

J.P. Morgan

Full Bio

Peter Scher

Vice Chairman,

JPMorgan Chase & Co.

Full Bio

Jamie Dimon

Chairman and Chief Executive Officer

JPMorgan Chase & Co.

Jamie Dimon is Chairman of the Board and Chief Executive Officer of JPMorgan Chase & Co., a global financial services firm with assets of $2.5 trillion and operations worldwide. The firm is a leader in investment banking, financial services for consumers, small business, commercial banking, financial transaction processing and asset management. Dimon became CEO on January 1, 2006 and one year later also became Chairman of the Board. He was named President and Chief Operating Officer upon the company’s merger with Bank One Corporation on July 1, 2004. Dimon joined Bank One as Chairman and CEO in 2000. Dimon began his career at American Express Company. Next, he served as Chief Financial Officer and then President at Commercial Credit, which made numerous acquisitions and divestitures, including acquiring Prim-erica Corporation in 1987 and The Travelers Corporation in 1993. Dimon served as President and Chief Operating Officer of Travelers from 1990 through 1998 while concurrently serving as Chief Operating Officer of its Smith Barney Inc. subsidiary before becoming co-Chairman and Co-CEO of the combined brokerage following the 1997 merger of Smith Barney and Salomon Brothers. In 1998, Dimon was named President of Citigroup Inc., the global financial services company formed by the combination of Travelers Group and Citicorp. Dimon earned his bachelors degree from Tufts University and holds an M.B.A. from Harvard Business School. He serves on the boards of directors of a number of non-profit institutions including the Clearing House and Harvard Business School. Additionally, he is the Chairman of the Business Roundtable and serves on the executive committee of the Business Council and the Partnership for New York City, and is a member of the Financial Services Forum, Financial Services Roundtable and Council on Foreign Relations.

Jessica Fye

Managing Director,

Equity Research - Biotech,

J.P. Morgan

Jessica Fye is a Managing Director and Senior Analyst covering the U.S. SMid Cap Biotechnology sector with past coverage including Major and Specialty Pharmaceuticals. She has ranked in the top 3 in Mid- & Small-Cap Biotech by Institutional Investor, in addition to being recognized for multiple years as Runner-Up. Prior to that, she was a member of J.P. Morgan’s Institutional Investor-ranked Pharmaceuticals team. Before joining J.P. Morgan in 2008, Jessica worked in equity research at Bank of America focused on U.S. and European Major Pharma. She holds a BA in Business Economics from Brown University.

Peter Scher

Vice Chairman,

JPMorgan Chase & Co.

Peter L. Scher is Vice Chairman of JPMorgan Chase & Co. and a member of the firm’s Operating Committee. Scher is the firm’s senior business executive for the Mid-Atlantic region—one of the largest economic regions in the United States—and oversees the firm’s global Corporate Responsibility department, including its public policy efforts, the J.P. Morgan International Council and Morgan Health, a new business unit focused on improving the quality of healthcare for the firm’s employees and creating new models for employer-based healthcare. Previously, he was the Managing Partner of the Washington, D.C. office of law firm Mayer Brown LLP and earlier served as the Chairman of their Government and Global Trade Practice. He also spent nearly a decade in public service, serving as the U.S. Special Trade Ambassador under President Clinton.

Dan Mendelson

CEO, Morgan Health

Full Bio

Dan Mendelson

CEO, Morgan Health

Dan Mendelson is the Chief Executive Officer of Morgan Health at JPMorgan Chase & Co. Mendelson oversees a business unit at JPMorgan Chase focused on accelerating the delivery of new care models that improve the quality, equity and affordability of employer-sponsored healthcare. Mendelson was previously Founder and CEO of Avalere Health, a healthcare advisory company based in Washington, D.C. He also served as Operating Partner at Welsh Carson, a private equity firm. Before founding Avalere, Mendelson served as associate director for Health at the Office of Management and Budget in the Clinton White House. Mendelson currently serves on the boards of Vera Whole Health and Champions Oncology (CSBR). He is also an adjunct professor at the Georgetown University McDonough School of Business. He previously served on the boards of Coventry Healthcare, HMS Holdings, Pharmerica, Partners in Primary Care, Centrexion, and Audacious Inquiry. Mendelson holds a Bachelor of Arts (BA) from Oberlin College, and a Master of Public Policy (MPP) from the Kennedy School of Government at Harvard University.

Dr. Mark McClellan

MD, PhD

Full Bio

Dr. Mark McClellan

MD, PhD - Robert J. Margolis Professor of Business, Medicine, and Policy, and founding Director of the Duke-Margolis Center for Health Policy at Duke University

Mark McClellan, MD, PhD, is Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Policy at the Margolis Center for Health Policy at Duke University. He is a physician-economist who focuses on quality and value in health care, including payment reform, real-world evidence and more effective drug and device innovation. Dr. McClellan is at the center of the nation’s efforts to combat the pandemic and the author of a roadmap that details the steps needed for a comprehensive COVID-19 response and safe reopening of our country. He is former administrator of the Centers for Medicare & Medicaid Services and former commissioner of the U.S. Food and Drug Administration, where he developed and implemented major reforms in health policy. Dr. McClellan is an independent director on the boards of Johnson & Johnson, Cigna, Alignment Healthcare, and PrognomIQ; co-chairs the Guiding Committee for the Health Care Payment Learning and Action Network; and serves as an advisor for Arsenal Capital Group, Blackstone Life Sciences, and MITRE.

Andrew Bindman

MD, EVP and Chief Medical Officer,

Kaiser Permanente

Full Bio

Andrew Bindman

MD, EVP and Chief Medical Officer

Kaiser Permanente

Andrew Bindman, MD, is executive vice president and chief medical officer for Kaiser Permanente. He is responsible for driving superior quality and equitable health outcomes through the integration of quality innovation, care delivery, and research in collaboration with the Permanente Medical Groups. He is also Kaiser Permanente’s executive sponsor for the Kaiser Permanente Bernard J. Tyson School of Medicine. Dr. Bindman previously spent more than 30 years at the University of California, San Francisco where he practiced and taught clinical medicine while conducting research in health access and outcomes that resulted in more than 180 published scientific articles. A noted policy expert, he has held advisory and leadership roles for the U.S. House Energy and Commerce Committee, the U.S. Department of Health and Human Services, the Healthy California for All Commission, and the Agency for Healthcare Research and Quality. Dr. Bindman is a graduate of Harvard College and the Mount Sinai School of Medicine. A board-certified general internist, he completed his residency in internal medicine at UCSF and was a Robert Wood Johnson Foundation Clinical Scholar at Stanford University. He was elected to the National Academy of Medicine in 2015, where he currently serves on the board for health care services and chairs the workshops on diagnostic excellence. In 2021, he was elected to the Association of American Physicians in recognition for his notable contributions to advancing scientific and practical medicine.

Bertha Coombs

CNBC Reporter

Full Bio

Bertha Coombs

CNBC Reporter

Bertha Coombs is a reporter for CNBC, covering financial markets, business news stories and health care throughout the business day. Her health care coverage has focused on health care service companies, including health insurers, hospitals and pharmacies, as well as the growing impact of digital health technology on the health care industry, ranging from the explosion of telehealth in the wake of the COVID pandemic to the companies trying to change the way primary care is delivered. In nearly two decades at CNBC, she has also covered technology firms from the Nasdaq Marketsite, the energy markets from the former floor of the New York Mercantile Exchange, as well as reported on the fallout of the 2008 financial crisis, and issues such as the growing impact of Latinos in the U.S. economy, and the push to improve health equity in the wake of social unrest in 2020. Before joining CNBC, Coombs was a reporter and anchor for the pioneering streaming business network, Yahoo Finance Vision. Prior, she served as a reporter for ABC News One, substitute anchor for “World News Now” and “World News This Morning,” after local news reporting jobs in New York and Miami. Coombs is a graduate of Yale University and was awarded the Leo Beranek Reporter Training Fellowship at WCVB-TV in Boston. Born in Havana, Cuba, she speaks fluent Spanish.

Jean Hynes

CEO, Wellington Management

Full Bio

Jean Hynes

CEO, Wellington Management

As the chief executive officer of Wellington Management Company LLP, Jean leads the firm in our mission to drive excellence for clients to positively impact millions of beneficiaries’ lives. In pursuit of that mission, she spends significant time meeting with clients globally as well as working to strengthen and support the firm’s people and capabilities. She also serves on a variety of internal management committees, including the executive, operating, and compensation committees. In addition, she is one of the firm’s three managing partners, who are responsible for governance of the Wellington Management partnership, and she is the portfolio manager of the Vanguard Healthcare Fund. Throughout her 30 years at the firm, Jean has been a member of Wellington’s Global Industry Research Group and previously has had a number of responsibilities including researching the pharmaceutical and biotechnology industries, serving as a health care portfolio manager for a number of long and long/short strategies, and leading the Health Care Sector Research Team. Jean joined Wellington Management upon her graduation from Wellesley College (1991), where she was awarded a BA in economics. Additionally, she holds the Chartered Financial Analyst designation and is a member of the CFA Institute and the CFA Society Boston. She is also a member of the Investment Committee at Wellesley College.

Julie Murphy

Health Care Sector Specialist on the J.P. Morgan Trading Desk

Full Bio

Julie Murphy

Health Care Sector Specialist on the J.P. Morgan Trading Desk

Julie Murphy is the U.S. Healthcare Sector Specialists on the J.P. Morgan Equities Sales & Trading Team. In her current role, she works closely with the J.P. Morgan Healthcare Research Team leveraging fundamental research and market insights to provide dynamic perspectives on the Healthcare Sector. Prior to joining J.P. Morgan in 2017, Julie worked in a similar capacity at Morgan Stanley. She began her career in Healthcare Equities on the Morgan Stanley Equity Research Team. Julie graduated from The College of The Holy Cross in 2011 where she majored in History with minors in Philosophy and Mathematics.

Insights

Jess Fye

Senior Analyst, U.S. Biotechnoloy J.P. Morgan Research

Video Player is loading.

Current Time 0:00

Duration 2:22

Loaded: 6.91%

0:00

Stream Type LIVE

Remaining Time -2:22

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

en (Main), selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Jess Fye

Senior Analyst, U.S. Biotechnoloy J.P. Morgan Research

Chris Schott

Senior Analyst, U.S Major and Specialist Pharmaceuticals J.P. Morgan Research

Video Player is loading.

Current Time 0:00

Duration 2:51

Loaded: 5.79%

0:00

Stream Type LIVE

Remaining Time -2:51

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

en (Main), selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Chris Schott

Senior Analyst, U.S Major and Specialist Pharmaceutical

FAQs

How do I register for the conference?

The J.P. Morgan Health Care Conference is for clients of the firm, by invitation only. Please reach out to your J.P. Morgan representative to inquire about an invitation.

Can I listen to company presentation if I’m not registered for the conference?

Some company presentations will be available on their individual websites.

Where do I get the agenda?

The agenda is made available only to confirmed attendees.

Are media permitted to attend the conference?

Yes; there are a limited number of press passes for the event.

What is your media policy?

Unless otherwise specified, conference webinars are on-the-record and open to registered members of the press.

You're now leaving J.P. Morgan

J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.

Cancel Proceed

40th Annual J.P. Morgan Health Care Conference January 10 – 13, 2022 | Virtual

Keynotes

Jamie Dimon

Chairman and Chief Executive Officer,

JPMorgan Chase & Co.

Jessica Fye

Managing Director, Equity Research - Biotech,

J.P. Morgan

Peter Scher

Vice Chairman,

JPMorgan Chase & Co.

Dan Mendelson

CEO, Morgan Health

Dr. Mark McClellan

MD, PhD

Andrew Bindman

MD, EVP and Chief Medical Officer,

Kaiser Permanente

Bertha Coombs

CNBC Reporter

Jean Hynes

CEO, Wellington Management

Julie Murphy

Health Care Sector Specialist on the J.P. Morgan Trading Desk

Insights

Jess Fye

Jess Fye

Chris Schott

Chris Schott

FAQs

How do I register for the conference?

Can I listen to company presentation if I’m not registered for the conference?

Where do I get the agenda?

Are media permitted to attend the conference?

What is your media policy?

Related Insights

in-person @jpmorgan

Innovation in Pharma

Global Research Reports

40th Annual J.P. Morgan
Health Care Conference
January 10 – 13, 2022 | Virtual